SEC Form 4 · accession 0001902610-26-000002
Xtant Medical Holdings, Inc. · XTNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott C Neils
Officer — CFO and Assistant Secretary
Period of report
Aug 15, 2026
Accepted (ET)
Aug 18, 2026 · 5:54 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001453593
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 15, 2026 | A | 400,000 | $0.00 | A | 1,243,381 | D | |
| Common StockF3,F2 | Aug 15, 2026 | F | 28,155 | $0.31 | D | 1,215,226 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares will vest with respect to 100,000 shares on each of August 15, 2027, August 15, 2028, August 15, 2029, and August 15, 2030 pursuant to a deferred stock unit (DSU) award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan, conditioned upon the Reporting Person remaining an employee of Xtant through the applicable vesting date. The settlement of the vested shares underlying the DSU award has been deferred and will occur at a later date pursuant to the terms of the DSU award agreement. Each DSU represents a contingent right to receive one share of the Issuer's common stock.
- F2Includes an aggregate of 869,878 shares issuable upon vesting and settlement of restricted stock unit awards or DSU awards granted under the Xtant Medical Holdings, Inc. Amended and Restated 2023 Equity Incentive Plan conditioned upon the Reporting Person remaining an employee of Xtant through the respective vesting dates.
- F3These shares were withheld by the Issuer to pay tax withholding obligations upon vesting and settlement of restricted stock unit awards.